// App-Quantinova.ai

P389 : Indicators for inadequate response to advanced therapy in patients with Ulcerative Colitis: results from a medical chart review in the United Kingdom

Researchers

Presenter

  • Lindsay, J

Principal Investigators

  • Picker, N

  • Kromer, D

  • Smyth, M

  • Patel, H

Medical Centers

  • Barts and the London School of Medicine- Queen Mary University of London, Centre for Immunobiology- Blizard Institute, London, United Kingdom

  • Ingress Health HWM GmbH, Wismar, Germany

  • Galapagos, Uk, Cambridge, United Kingdom

  • Galapagos, Mechelen, Belgium

Locations

  • United Kingdom

  • Germany

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Ulcerative colitis

Biomarkers

  • N/A

Drug/Treatment

  • Entyvio

  • Tasocitinib

  • Adalimumab

  • Infliximab

  • golimumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved